Cartesian Therapeutics (RNAC) Total Current Liabilities (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Total Current Liabilities of $15.9 million for Q1 2026, up 6.31% year-over-year from $15.0 million in Q1 2025, and up 6.75% quarter-over-quarter from $14.9 million in Q4 2025.
Cartesian Therapeutics (RNAC) Total Current Liabilities (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Total Current Liabilities for 12 consecutive years, with $15.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 6.31% year-over-year to $15.9 million; the TTM figure through Mar 2026 stood at $15.9 million (up 6.31% YoY), while the FY2025 annual figure was $14.9 million, down 34.99% from the prior year.
- Total Current Liabilities rose to $15.9 million in Q1 2026 per RNAC's latest filing, from $14.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $68.2 million in Q4 2023 and bottomed at $12.3 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $26.2 million across 5 years, with a median of $23.7 million in 2022.
- Annual changes were most pronounced in 2022 — Total Current Liabilities sank 75.18% — and 2023, when it soared 172.0%.
- Cartesian Therapeutics' Total Current Liabilities stood at $25.1 million in 2022, then jumped by 172.0% to $68.2 million in 2023, then plunged by 66.32% to $23.0 million in 2024, then slumped by 34.99% to $14.9 million in 2025, then grew by 6.75% to $15.9 million in 2026.
- Business Quant data shows RNAC's Total Current Liabilities at $15.9 million in Q1 2026, $14.9 million in Q4 2025, and $13.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | 20.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.55 Mn |
| Mar 31, 2026 | 15.95 Mn |
| Dec 31, 2025 | 14.94 Mn |
| Sep 30, 2025 | 13.80 Mn |
| Jun 30, 2025 | 12.26 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 22.98 Mn |
| Sep 30, 2024 | 21.41 Mn |
| Jun 30, 2024 | 26.12 Mn |
| Mar 31, 2024 | 36.65 Mn |
| Dec 31, 2023 | 68.21 Mn |
| Sep 30, 2023 | 19.94 Mn |
| Jun 30, 2023 | 29.37 Mn |
| Mar 31, 2023 | 26.53 Mn |
| Dec 31, 2022 | 25.08 Mn |
| Sep 30, 2022 | 23.73 Mn |
| Jun 30, 2022 | 33.76 Mn |
| Mar 31, 2022 | 39.25 Mn |
| Dec 31, 2021 | 72.25 Mn |
| Sep 30, 2021 | 95.62 Mn |